Newcastle Disease resurgence in Europe highlights importance of proper vaccine implementation against emerging genotypes
Newcastle Disease has re-emerged across Europe with confirmed outbreaks in Poland, Czech Republic, Germany, Spain and Hungary since 2024, though current vaccines remain effective against Genotype VII because all field strains share the same serotype. Most outbreaks in vaccinated flocks result from failures in vaccination delivery or immune response rather than vaccine ineffectiveness, underscoring the importance of proper implementation and transmission control measures. HVT-vectored vaccines such as Vectormune ND can significantly reduce disease transmission rates in affected poultry populations.
Newcastle Disease has been largely absent from Western Europe for decades, making the current resurgence particularly striking. The recent outbreak confirmed in Hungary in September 2026 represents the country's first documented case in commercial poultry operations since 1992, while Germany experienced over 60 confirmed cases across major production regions after remaining disease-free for 30 years. Spain has proven especially vulnerable, with infections affecting millions of birds across multiple regions since the virus's reappearance in late 2025.
The virus responsible for current European outbreaks belongs to Genotype VII, prompting concerns about vaccine efficacy. However, all circulating Newcastle Disease strains share the same serotype classification, meaning existing vaccines like LaSota and B1 retain their ability to neutralize the virus. When vaccinated flocks do become infected, investigations typically reveal failures in vaccine application techniques or the vaccinated bird's immune response rather than fundamental vaccine inadequacy.
The resurgence poses significant economic and regulatory consequences for European poultry producers. Since Newcastle Disease requires mandatory flock depopulation under EU law alongside movement restrictions and export bans, affected producers face financial losses comparable to avian influenza outbreaks. Widespread disease circulation could disrupt poultry supply chains and increase consumer food costs, while improved vaccination practices and transmission control measures may help contain further spread and protect farm viability across the continent.